PCN126 REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.322
https://www.valueinhealthjournal.com/article/S1098-3015(19)32700-7/fulltext
Title : PCN126 REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32700-7&doi=10.1016/j.jval.2019.09.322
First page :
Section Title :
Open access? : No
Section Order : 10263
Categories :
Tags :
Regions :
ViH Article Tags :